Literature DB >> 21621411

Practical synthesis, anticonvulsant, and antimicrobial activity of N-allyl and N-propargyl di(indolyl)indolin-2-ones.

Chandrasekaran Praveen1, Asairajan Ayyanar, Paramasivan Thirumalai Perumal.   

Abstract

An operation friendly protocol for the synthesis of novel di(indolyl)indolin-2-ones via Cu(OTf)(2) catalyzed bis-addition of N-allyl and N-propargyl indole with isatin was developed. This methodology allowed us to achieve the products in excellent yields without requiring purification technique like column chromatography. All the synthesized compounds were evaluated for their in vivo anticonvulsant activity against maximal electroshock test. Six compounds showed maximum activity compared to the standard drug phenytoin. The scope of the new molecules as antimicrobial agents were tested against two bacterial strains (Staphylococcus aureus and Escherichia coli) and one fungal strain (Candida albicans).
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21621411     DOI: 10.1016/j.bmcl.2011.04.117

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Chemistry of trisindolines: natural occurrence, synthesis and bioactivity.

Authors:  First Ambar Wati; Mardi Santoso; Ziad Moussa; Sri Fatmawati; Arif Fadlan; Zaher M A Judeh
Journal:  RSC Adv       Date:  2021-07-21       Impact factor: 4.036

2.  A mini library of novel triazolothiadiazepinylindole analogues: synthesis, antioxidant and antimicrobial evaluations.

Authors:  Jaiprakash Sharanappa Biradar; Parveen Rajesab; Naveen Jaiprakash Biradar; Sasidhar Balappa Somappa
Journal:  ScientificWorldJournal       Date:  2014-02-20

3.  Design, synthesis and biological evaluation of novel bromophenol derivatives incorporating indolin-2-one moiety as potential anticancer agents.

Authors:  Li-Jun Wang; Shuai-Yu Wang; Bo Jiang; Ning Wu; Xiang-Qian Li; Bao-Cheng Wang; Jiao Luo; Meng Yang; Shui-Hua Jin; Da-Yong Shi
Journal:  Mar Drugs       Date:  2015-02-02       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.